Literature DB >> 7318878

Absorption of quinidine and dihydroquinidine in humans.

D M Hailey, A R Lea, D M Coles, P E Heaume, W J Smith.   

Abstract

Quinidine and dihydroquinidine were administered as the sulphates in an oral solution to seven healthy volunteers. In all subjects, dihydroquinidine was absorbed to a lesser extent than quinidine. On the basis of comparative AUC pu to 6 h after administration, dihydroquinidine was 73% as available as quinidine. Rates of elimination of the compounds were similar. No correlation could be found between saliva and plasma levels for either compound. Limits for content of dihydroquinidine in commercial quinidine preparations seem essential to ensure adequate bioavailability.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318878     DOI: 10.1007/bf00627920

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Relationship between quinidine plasma and saliva levels in humans.

Authors:  J M Jaffe; J D Strum; P C Martineau; J L Colaizzi
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Disposition kinetics of dihydroquinidine following quinidine administration.

Authors:  C T Ueda; B J Williamson; B S Dzindzio
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-06

3.  Examination of quinidine and quinine and their pharmaceutical preparations.

Authors:  E Smith; S Barkan; B Ross; M Maienthal; J Levine
Journal:  J Pharm Sci       Date:  1973-07       Impact factor: 3.534

4.  Quinidine kinetics in congestive heart failure.

Authors:  C T Ueda; B S Dzindzio
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

5.  Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods.

Authors:  T W Guentert; R A Upton; N H Holford; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

6.  Specific serum quinidine assay by high-performance liquid chromatography.

Authors:  W G Crouthamel; B Kowarski; P K Narang
Journal:  Clin Chem       Date:  1977-11       Impact factor: 8.327

7.  THE RELATIONSHIP OF DOSAGE SCHEDULE TO THE BLOOD LEVEL OF QUINIDINE, USING ALL AVAILABLE QUINIDINE PREPARATIONS.

Authors:  W M GOLDBERG; S G CHAKRABARTI
Journal:  Can Med Assoc J       Date:  1964-11-07       Impact factor: 8.262

8.  [Studies on antiarrhythmic effects and toxicity of quinidine and dihydroquinidine as well as defined mixtures of both in rats (author's transl)].

Authors:  K Dietmann; W Bartsch; M Gutekunst
Journal:  Arzneimittelforschung       Date:  1977

9.  Quinidine and dihydroquinidine interactions in human plasma.

Authors:  C T Ueda; M C Makoid
Journal:  J Pharm Sci       Date:  1979-04       Impact factor: 3.534

10.  Comparison of effects of quinidine and dihydroquinidine on canine heart.

Authors:  T Balazs; E Herman; J Atkinson
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

View more
  1 in total

1.  Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.

Authors:  M Chimienti; M B Regazzi; M T La Rovere; J A Salerno; M Previtali; V Montericcio; R Rondanelli; C Montemartini
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.